Evidence map›Paper›PMID 25657638›Full record

ArticleFrontiers in endocrinology2014

Global O-GlcNAc Levels Modulate Transcription of the Adipocyte Secretome during Chronic Insulin Resistance.

Edith E Wollaston-Hayden, Ruth B S Harris, Bingqiang Liu, Robert Bridger, Ying Xu, Lance Wells

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Anti-Obesity and Anti-Hyperglycemic Effects ofInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. O-GlcNAcylation of core components of the translation initiation machinery regulates protein synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Review
  9. Biosynthesis ofThe Journal of biological chemistry · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Edith E Wollaston-HaydenComplex Carbohydrate Research Center, University of Georgia , Athens, GA , USA ; Department of Biochemistry and Molecular Biology, University of Georgia , Athens, GA , USA.
Ruth B S HarrisDepartment of Physiology, Georgia Health Sciences University , Augusta, GA , USA.
Bingqiang LiuDepartment of Biochemistry and Molecular Biology, University of Georgia , Athens, GA , USA.
Robert BridgerComplex Carbohydrate Research Center, University of Georgia , Athens, GA , USA.
Ying XuDepartment of Biochemistry and Molecular Biology, University of Georgia , Athens, GA , USA.
Lance WellsComplex Carbohydrate Research Center, University of Georgia , Athens, GA , USA ; Department of Biochemistry and Molecular Biology, University of Georgia , Athens, GA , USA.
University of Georgia · USAugusta University Health · US

Funding

LEPTIN AND PERIPHERAL GLUCOSE METABOLISMR01DK053903 · NIDDK · UNIVERSITY OF GEORGIA (UGA) · PI HARRIS, RUTH B · 1999 to 2018
$4.6M
Role of O-GlcNAc in Metabolic SignalingR01DK075069 · NIDDK · UNIVERSITY OF GEORGIA · PI WELLS, LANCE · 2007 to 2011
$1.4M
NIDDK NIH HHS R01 DK053903NIDDK NIH HHS R01 DK075069
6 · The paper itself

Abstract

Increased flux through the hexosamine biosynthetic pathway and the corresponding increase in intracellular glycosylation of proteins via O-linked β-N-acetylglucosamine (O-GlcNAc) is sufficient to induce insulin resistance (IR) in multiple systems. Previously, our group used shotgun proteomics to identify multiple rodent adipocytokines and secreted proteins whose levels are modulated upon the induction of IR by indirectly and directly modulating O-GlcNAc levels. We have validated the relative levels of several of these factors using immunoblotting. Since adipocytokines levels are regulated primarily at the level of transcription and O-GlcNAc alters the function of many transcription factors, we hypothesized that elevated O-GlcNAc levels on key transcription factors are modulating secreted protein expression. Here, we show that upon the elevation of O-GlcNAc levels and the induction of IR in mature 3T3-F442a adipocytes, the transcript levels of multiple secreted proteins reflect the modulation observed at the protein level. We validate the transcript levels in male mouse models of diabetes. Using inguinal fat pads from the severely IR db/db mouse model and the mildly IR diet-induced mouse model, we have confirmed that the secreted proteins regulated by O-GlcNAc modulation in cell culture are likewise modulated in the whole animal upon a shift to IR. By comparing the promoters of similarly regulated genes, we determine that Sp1 is a common cis-acting element. Furthermore, we show that the LPL and SPARC promoters are enriched for Sp1 and O-GlcNAc modified proteins during insulin resistance in adipocytes. Thus, the O-GlcNAc modification of proteins bound to promoters, including Sp1, is linked to adipocytokine transcription during insulin resistance.

Indexed as

adipocytokinesadipose tissueinsulin resistanceO-GlcNActranscription

Identifiers

PMID25657638
PMCPMC4302944
OpenAlexW2057256358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.